Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Abram Scientific awarded up to $8.3M DARPA contract to advance CoagCare blood coagulation diagnostics for trauma care.
CaliforniaBiotechnologyHealth CareMedicalMedical DeviceHealth DiagnosticsDescription
Abram Scientific has received a contract of up to $8.3 million from the Defense Advanced Research Projects Agency (DARPA) to advance its CoagCare rapid, handheld blood coagulation testing platform for trauma settings. The funding supports the development of point-of-care diagnostics under DARPA's RAPIID program, which aims to develop shelf-stable blood analogs and rapid diagnostic tools. This award follows a $2 million DARPA contract Abram Scientific received in October 2025 for CoagCare system miniaturization. The CoagCare platform combines a compact meter with single-use diagnostic test cards to assess blood coagulation status in austere and resource-limited environments.
Related People
Abram Scientific signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.